Tizanidin

ATC CodeM03BX02
CAS number51322-75-9
PUB number5487
Drugbank IDDB00697
Empirical formulaC9H8ClN5S
Molar mass (g·mol−1)253,71
Physical statesolid
Melting point (°C)221–223
PKS value7.48

Basics

Tizanidine is a so-called alpha-2-receptor agonist and a representative of the group of centrally acting muscle relaxants. The main areas of application are the treatment of painful muscle tension, for example due to spinal complaints, the treatment after operations (e.g.: after herniated disc) or the symptomatic treatment of multiple sclerosis. Tizanidine requires a prescription and is mainly given in the form of tablets or capsules.

Pharmacology

Pharmacodynamics

Tizanidine binds with high affinity to alpha-2-adrenoreceptors, primarily in the patient's spinal cord. This inhibits the activity of excitatory amino acids, which are responsible for the excessive muscle tone. In addition to its relaxing effect, tizanidine also has moderate analgesic properties.

Pharmacokinetics

Tizanidine is absorbed through the intestine. Oral bioavailability is only 40% which is why the dose should be adjusted accordingly. Tizanidine is bound to plasma proteins at a rate of approximately 30%. The drug is degraded in the liver by the enzyme CYP1A2. The half-life averages about 2.5 hours and final elimination is almost entirely by the kidneys.

Drug interactions

Drugs that inhibit the enzyme CYP1A2 should not be taken concomitantly with tizanidine, as life-threatening elevated plasma levels of the drug may occur. These include: Fluvoxamine, ciprofloxacin, amiodarone, propafenone and mexiletine, cimetidine and some fluoroquinolones. Furthermore, a combination with the following substances is contraindicated: QT interval prolonging substances, antihypertensives, diuretics, beta-blockers, oral contraceptives and alcohol or other centrally depressant substances.

Toxicity

Possible side effects are:

  • Drowsiness, fatigue, dizziness.
  • bradycardia, tachycardia
  • hypotension, rebound hypertension
  • dry mouth, nausea, gastrointestinal disturbances

Use during pregnancy or lactation is not recommended. Tizanidine should be used here only if the benefit clearly outweighs the risk.

Toxicological data

LD50 (rat, oral): 414 mg/kg

Markus Falkenstätter, BSc

Markus Falkenstätter, BSc

Mag. pharm. Stefanie Lehenauer

Mag. pharm. Stefanie Lehenauer



Logo

Your personal medication assistant

Drugs

Browse our extensive database of medications from A-Z, including effects, side effects, and dosage.

Substances

All active ingredients with their effects, applications, and side effects, as well as the medications they are contained in.

Diseases

Symptoms, causes, and treatments for common diseases and injuries.

Social media

The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.

© medikamio